CNCE Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 apr 2024 @ 22:00):

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases...

Stats
Dagens volum	10.73M
Gjennomsnittsvolum	0.00
Markedsverdi	401.95M
EPS	$0 ( 2023-08-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.64
ATR14	$0.231 (2.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-06	Van Heek Christi	Sell	25 651	Common Stock
2023-03-06	Van Heek Christi	Sell	16 400	Common Stock
2023-03-06	Van Heek Christi	Sell	25 000	Stock Option (Right to Buy)
2023-03-06	Van Heek Christi	Sell	10 000	Stock Option (Right to Buy)
2023-03-06	Van Heek Christi	Sell	10 000	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 \| Sell: 4 463 235

Volum Korrelasjon

Lang: 0.24 (neutral)

Kort: -0.57 (weak negative)

Signal:(66.67) Neutral

Concert Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
NNOX	0.949
NERV	0.942
TYHT	0.942
MESA	0.94
RVNC	0.935
IDYA	0.932
PIRS	0.929
CELH	0.928
LIXT	0.928
MBINO	0.927

10 Mest negative korrelasjoner
TWKS	-0.963
FNWB	-0.958
HMST	-0.951
TCPC	-0.949
UPLD	-0.948
INFI	-0.942
EYE	-0.941
VNET	-0.94
SABRP	-0.939
TBNK	-0.938

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Concert Pharmaceuticals Korrelasjon - Valuta/Råvare

0.81
( strong )

0.84
( strong )

-0.59
( weak negative )

0.62
( weak )

0.13
( neutral )

-0.41
( neutral )

Concert Pharmaceuticals Økonomi

Annual	2021
Omsetning:	$32 578.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.00233

FY	2021
Omsetning:	$32 578.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.00233

FY	2020
Omsetning:	$7.90M
Bruttogevinst:	$7 902.00 (0.10 %)
EPS:	$-2.40

FY	2019
Omsetning:	$1.08M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.29

Financial Reports:

No articles found.

Concert Pharmaceuticals

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.